Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Esperion Therapeutics
Biotech
Cholesterol-focused Esperion loses appetite for Serometrix pact
Esperion says it no longer needs Serometrix's help developing scaffolding compounds for an oral PCSK9 candidate.
Max Bayer
Aug 1, 2023 10:46am
Esperion tees up to launch cholesterol-busting meds—affordably
Jan 14, 2020 8:30am
Esperion's cholesterol-lowering drug clears test in diabetics
Aug 29, 2019 9:05am
Esperion shares yo-yo as NEJM papers downplay cancer death data
Mar 14, 2019 10:24am
Safety update sets up filings for Esperion cholesterol drug
Oct 29, 2018 10:46am
Esperion’s cholesterol drug cuts LDL-C in phase 3
Aug 27, 2018 8:55am
